StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 19, 2026, 06:17 AM

Natural Alternatives Q3 Net Loss $4.3M; Sales Up 23% to $35.5M

AI Summary

Natural Alternatives International, Inc. reported a net loss of $4.3 million, or $0.72 per diluted share, for the third quarter of fiscal year 2026, an increase from $2.2 million loss in the prior year, despite a 23% rise in net sales to $35.5 million. The loss was primarily attributed to underutilization of factory capacities. For the nine months ended March 31, 2026, the company posted a net loss of $7.2 million on net sales of $108.0 million. The company also announced a new Loan and Security Agreement with Legacy Corporate Lending, LLC, providing an $11.0 million term loan and a $20.0 million working capital line to support anticipated sales growth and strategic initiatives.

Key Highlights

  • Reported Q3 FY2026 net loss of $4.3 million, or $0.72 per diluted share.
  • Q3 FY2026 net sales increased 23% to $35.5 million compared to prior year.
  • Private-label contract manufacturing sales rose 25% to $33.8 million in Q3 FY2026.
  • Nine-month net loss was $7.2 million, or $1.19 per diluted share.
  • Nine-month net sales increased 13% to $108.0 million.
  • Secured new credit facility with $11.0 million term loan and $20.0 million working capital line.
  • Cash was $9.2 million and working capital $24.9 million as of March 31, 2026.
  • Anticipates a net loss for Q4 and the full fiscal year 2026.